| Literature DB >> 33497703 |
Xiaolu Zheng1, Shixiong Kang1, Ke Wang1, Yaoyao Yang1, Deng-Guang Yu2, Fuxian Wan3, Gareth R Williams4, Sim-Wan Annie Bligh5.
Abstract
In nature, the combination of composition, structure, and shape determines the matter's functional performance to a large extent. Inspired by which, two electrospun Janus nanofiber formulations were created using side-by-side electrospinning in this work. Tamoxifen citrate (TAM) was used as a model drug and ethyl cellulose (EC) and polyvinylpyrrolidone K60 (PVP) as the polymer carrier matrices. The fibers have linear cylindrical morphologies and distinct Janus structures by scanning electron microscopy. One side of the fibers took a round shape, while the other was crescent-shaped. The drug was present in both polymer matrices in the form of amorphous solid dispersions, owing to strong intermolecular interactions between drug and polymer. In vitro dissolution tests demonstrated that both sets of fibers could provide biphasic drug release due to the difference in solubility of PVP and EC. The different shape of TAM-EC and TAM-PVP side of the Janus structure resulted in a considerable variation in the drug release profiles. The Janus structure with crescent TAM-PVP side and round TAM-EC side gave a more rapid burst release in the first phase of release, and slower sustained release in the second phase. This work thus reports a new strategy for systematically developing advanced functional nanomaterials based on both shape- and structure-performance relationships.Entities:
Keywords: Basic fuchsin (PubChem CID: 3081760); Biphasic release; Dichloromethane (PubChem CID: 6344); Ethanol (PubChem CID: 702); Ethyl cellulose (PubChem CID: 24832091); Janus nanostructure; Methylene blue (PubChem CID: 6099); Polyvinylpyrrolidone (PubChem CID: 6917); Shape-performance relationship; Side allocation; Side-by-side electrospinning; Sodium hydroxide (PubChem CID: 14798); Tamoxifen citrate (PubChem CID: 2733525)
Mesh:
Substances:
Year: 2021 PMID: 33497703 DOI: 10.1016/j.ijpharm.2021.120203
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875